a man gardening

Resources

Resources

Read recent press, publications, and announcements about Cognito and our Alzheimer’s treatment.

Scroll Down
All Time
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
30 Oct
2023
Neuromod tech developer Cognito Therapeutics has a new CCO
Press Releases
27 Oct
2023
Clinical Potential of Cognito’s Gamma Sensory Stimulation Device in Alzheimer Disease: Brent Vaughan
Press Releases
24 Oct
2023
Cognito Therapeutics Presents Phase 2 OVERTURE Study Open-Label Extension Data Showing Safety, Adherence and Durability of Treatment Benefits Over 18 Months
News Articles
18 Oct
2023
Cognito Therapeutics to Present Phase 2 OVERTURE Study Open-Label Extension Data Showing Safety and Durability of Treatment Benefits Over 18 Months at CTAD 2023
News Articles
17 Oct
2023
Cognito Therapeutics Appoints Greg Weaver as Chief Financial Officer
News Articles
17 Jul
2023
Cognito Therapeutics Presents New MRI Data Showing Non-Invasive Gamma Stimulation Therapy Reduces Brain Atrophy and Myelin Loss in Alzheimer’s Disease
News Articles
No results found.
There are no results with this criteria. Try changing your search.